Team Fundraising Goal: $146,175
$30,630
Quick Info
- Next Practice [09/07]: 6:30pm Strength Training @ Arcadia High
- Coach's Email NEW [08/26]
- Personalize Your Webpage!
- Write a Good Letter
- Sample Donor Form - Include with your letters
- Where to Send Your Checks
Recent Photos
LLS funds more blood cancer research than any other voluntary health agency. Many LLS-supported advances help beyond the blood cancer patients for whom they were first developed.
LLS support was instrumental in the development of Velcade®, the targeted treatment for patients with multiple myeloma, now also approved for mantle cell lymphoma.
LLS-funded researchers discovered the value of combining Rituxan® with standard chemotherapy resulting in the first survival rate improvement in 25 years for patients with diffuse large B-cell lymphoma.
An LLS funded researcher developed Gleevec®, a pill for chronic myelogenous leukemia (CML). Now, 95% of newly diagnosed, chronic-phase CML, patients survive more than five years with good quality of life.
Your Honored Teammates
Tyler CordovaDiagnosis: Non-Hodgkins Lymphoma & Leukemia
Diagnosed: March, 2007
Alessandra SanchezDiagnosis: Hodgkin’s Lymphoma
Diagnosed: February, 2009
Tatum Gumpf Diagnosis: Leukemia
Diagnosed: July, 2010
Virginia GarnerDiagnosis: Chronic Myelogenous Leukemia (CML)
Diagnosed: August, 1997
Roger KlinkhartDiagnosis: Chronic Lymphocytic Leukemia (CLL)
Diagnosed: February, 2003
Brecken Armstrong-KelseyDiagnosis: Non-Hodgkin’s Lymphoma
Diagnosed: 2007
tell us your story: click here
